The Dangerous Liaison Between Depression and Cardiovascular Disease: A Narrative Review of Epidemiology, Mechanisms, and Clinical Management.

Depression and cardiovascular disease (CVD) are two of the heaviest burdens carried by modern medicine, and a growing body of evidence now suggests that they are linked by a bidirectional, mutually reinforcing relationship rather than by a simple cause-and-effect chain. Patients with major depressive disorder appear to carry an elevated risk of incident coronary artery disease, heart failure, and stroke, while patients with established CVD, particularly those recovering from an acute coronary syndrome, frequently go on to develop clinically significant depressive symptoms that worsen prognosis independently of traditional risk factors. Several shared pathophysiological pathways help explain this dangerous liaison, among them autonomic dysfunction, dysregulation of the hypothalamic-pituitary-adrenal axis, chronic low-grade inflammation, platelet hyperreactivity, endothelial dysfunction, and unhealthy behavioral patterns that tend to accumulate once mood suffers. Despite this growing mechanistic understanding, translating this knowledge into effective treatment has proven far from straightforward: several randomized trials of antidepressants and psychotherapy have improved mood, yet they have not consistently reduced hard cardiovascular endpoints, with a handful of notable exceptions. This review brings together the current evidence on epidemiology, biological mechanisms, prognostic implications, and management strategies at the depression-CVD interface, and closes by outlining priorities for future research and for integrated cardiac-behavioral care.